Replies to post #110487 on Bioelectronics Corp (BIEL)

[chado]

Issues with Economic Study:

1. Only a 30 Person Test.
2. Only a 3-month Test.
3. Only done in the UK.

This is a TERRIBLE representation of the general population of pain users.
For one, the number of test subjects needs to be DRASTICALLY HIGHER. For second, it needs to span multiple age brackets, and multiple types of subjects with varying healthcare coverage / prescription coverage. Third, a small test in the UK doesn't mean a hill of beans to the USA population.

Can't BIEL do any better than a less than half-ass economic test. That was a FLUFF PR at it's worst. Pure FLUFF.

As a said earlier, it is likely "directionally" correct to say actipatch provides a net cost reduction...BUT, this test in NO WAY provides credibility to such an assumption because it was a poorly thought out test, nowhere near an accurate represention of the overall pain user population. 41% savings is likely a HUGE EMBELISHMENT...Even if it was a 10% savings, that 10% is still a GOOD savings. Why can't BIEL conduct a better test with more credible and believable results.

[Erbb]

Yes

FDA will do as kings there is a paperwork.

If biel waited for next year total different story. Wouldn't u think SO

[art2426]

This was no test, no trial. The UK has already been satisfied on their requirements to sell products in their country. They are totally aware of their safety and efficacy. And so has the FDA, so there is no need for a 'large sample size'. The NHS wanted the company to show them how it would be of benefit to them (NHS) for reimbursement to its citizens for the cost of buying/using the Actipatch. There is no stipulation as to the number of samples required for that. It is simple statistics, math and projection as to the benefit of the Actipatch reimbursement by the NHS when comparing that number to what they are now reimbursing for so many other pain therapies. How using the actipatch will eliminate much of those other expenses for pain, thus benefiting the NHS financially. No need for large sample size when projection is the key.

[uksausage]

the FDA accepted a 3 person test for a hand held laser device that supposedly relieves dental and other pain (cosmetic surgery).

I repeat

3 person trial

[DewmBoom]

The statisticians disagree with you. This is an acceptable statistical test. Also, what difference it makes if you and I accept or deny it. What matters is the NHS. They did it for them and not for you and me. You don't gain much statistically in representing the population when you go from 30 to 100.

THINK ABOUT IT